Gsa Capital Partners LLP T2 Biosystems, Inc. Transaction History

Gsa Capital Partners LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.09 - $565.0 $175,901 - $1.1 Billion	1,954,463 New	1,954,463 $221,000
Q4 2021 Feb 14, 2022	SELL	$0.46 - $0.94 $76,252 - $155,820	-165,766 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$0.86 - $1.21 $142,558 - $200,576	165,766 New	165,766 $152,000
Q1 2021 May 10, 2021	SELL	$1.32 - $3.79 $209,093 - $600,351	-158,404 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$1.06 - $1.51 $167,908 - $239,190	158,404 New	158,404 $196,000
Q3 2020 Nov 06, 2020	SELL	$1.15 - $2.1 $29,740 - $54,308	-25,861 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$0.48 - $1.67 $166,732 - $580,089	-347,359 Reduced 93.07%	25,861 $33,000
Q1 2020 May 12, 2020	BUY	$0.28 - $1.23 $104,501 - $459,060	373,220 New	373,220 $242,000
Q4 2018 Feb 12, 2019	SELL	$2.98 - $6.86 $96,900 - $223,066	-32,517 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.36 - $7.83 $174,291 - $254,608	32,517 New	32,517 $242,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.